Efficacy of combined Sofosbuvir and Daclatasvir in the treatment of COVID-19 patients with pneumonia: a multicenter Egyptian study.
- DOI
- 10.1080/14787210.2021.1950532
- Published
- 2022 Feb
- Container
- Expert review of anti-infective therapy
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/14787210.2021.1950532,
title = {Efficacy of combined Sofosbuvir and Daclatasvir in the treatment of COVID-19 patients with pneumonia: a multicenter Egyptian study.},
author = {El-Bendary M and Abd-Elsalam S and Elbaz T and El-Akel W and Cordie A and Elhadidy T and Elalfy H and Farid K and Elegezy M and El-Badrawy A and Neamatallah M and Abd Elghafar M and Salama M and AbdAllah M and Essam M and El-Shazly M and Esmat G},
year = {2022},
journal = {Expert review of anti-infective therapy},
doi = {10.1080/14787210.2021.1950532},
url = {https://doi.org/10.1080/14787210.2021.1950532}
}RIS
TY - JOUR TI - Efficacy of combined Sofosbuvir and Daclatasvir in the treatment of COVID-19 patients with pneumonia: a multicenter Egyptian study. AU - El-Bendary M AU - Abd-Elsalam S AU - Elbaz T AU - El-Akel W AU - Cordie A AU - Elhadidy T AU - Elalfy H AU - Farid K AU - Elegezy M AU - El-Badrawy A AU - Neamatallah M AU - Abd Elghafar M AU - Salama M AU - AbdAllah M AU - Essam M AU - El-Shazly M AU - Esmat G PY - 2022 JO - Expert review of anti-infective therapy DO - 10.1080/14787210.2021.1950532 UR - https://doi.org/10.1080/14787210.2021.1950532 ER -
APA
M, E., S, A., T, E., W, E., A, C., T, E., H, E., K, F., M, E., A, E., M, N., M, A. E., M, S., M, A., M, E., M, E., & G, E. (2022). Efficacy of combined Sofosbuvir and Daclatasvir in the treatment of COVID-19 patients with pneumonia: a multicenter Egyptian study.. Expert review of anti-infective therapy. https://doi.org/10.1080/14787210.2021.1950532
Source records
- pubmed · retrieved 2026-09-26T03:59:41.793Z